← FDA ENFORCEMENT
F-1207-2024Class II

BF Suma Pharmaceuticals, Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
BF Suma Pharmaceuticals, Inc.
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2024-05-08
Distribution
U.S. distribution to the following states: CA, TX. Foreign distribution to Canada and Guatemala.
Firm state
CA
Product quantity
15,528 boxes
Initiated by
Voluntary: Firm initiated
Reason for recall

Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil

Product description

Longreen Corporation 4 in1 Cordyceps Coffee, 18.2 grams/sachet, 10 sachets/box

Code / lot info

Batch No. C30919, Best By Date: 02 2026; Batch No. F34619, Best By Date: 05 2026; Batch No. F34719; Best By Date: 05 2026

Other recalls SPEQ maps to Documentation & Change Control
See all Documentation & Change Control recalls →

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →